Corient Private Wealth
OPK icon

Corient Private Wealth’s Opko Health OPK Stock Holding History

Corient Private Wealth’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1K Buy
+11,370
New +$14.5K ﹤0.01% 3027

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Corient Private Wealth's OPK Position: Q2 2026 in Review

Corient Private Wealth opened a new position in Opko Health (OPK) in Q2 2026: 11,370 shares worth $17.1K. The stake represents ﹤0.01% of the portfolio and ranks #3027 among its holdings.

222 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Corient Private Wealth held 11,370 shares of Opko Health worth $17.1K as of Q2 2026.
  • Opko Health was a new Corient Private Wealth position in Q2 2026.
  • Opko Health made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #3027 holding.
  • 222 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.